Insider: Laponis Adam Chief Financial Officer - Twist Bioscience Corp
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 128,291 | 0 | 128,291 |
| Value | $6,441,491.11 | $0.00 | $6,441,491.11 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/23/2026 | DDS | 2,085 | Direct | COM | $46.71 | $97,389.93 | 128,291 |
| 02/12/2026 | DDS | 7,000 | Direct | COM | $50.00 | $350,000.00 | 130,031 |
| 01/13/2026 | DDS | 3,000 | Direct | COM | $40.00 | $120,000.00 | 137,031 |
| 01/09/2026 | DDS | 2,738 | Direct | COM | $35.26 | $96,544.62 | 140,031 |
| 11/21/2025 | DDS | 887 | Direct | COM | $26.50 | $23,508.60 | 142,769 |
| 10/30/2025 | DDS | 5,517 | Direct | COM | $31.44 | $173,478.20 | 111,008 |
| 10/09/2025 | DDS | 2,517 | Direct | COM | $32.92 | $82,864.67 | 91,525 |
| 10/08/2025 | DDS | 3,000 | Direct | COM | $31.15 | $93,450.00 | 94,042 |
| 10/06/2025 | DDS | 5,875 | Direct | COM | $32.19 | $189,098.63 | 97,042 |
| 08/21/2025 | DDS | 918 | Direct | COM | $25.96 | $23,834.95 | 102,917 |
| 07/09/2025 | DDS | 2,449 | Direct | COM | $38.15 | $93,419.55 | 103,569 |
| 05/21/2025 | DDS | 936 | Direct | COM | $29.75 | $27,843.19 | 106,018 |
| 04/09/2025 | DDS | 2,542 | Direct | COM | $34.97 | $88,887.13 | 106,954 |
| 02/21/2025 | DDS | 918 | Direct | COM | $44.18 | $40,554.49 | 109,496 |
| 01/10/2025 | DDS | 5,886 | Direct | COM | $43.26 | $254,646.02 | 110,096 |
| 11/06/2024 | DDS | 4,160 | Direct | COM | $44.61 | $185,556.80 | 89,237 |
| 10/09/2024 | DDS | 856 | Direct | COM | $41.81 | $35,791.07 | 73,397 |
| 07/09/2024 | DDS | 842 | Direct | COM | $48.91 | $41,184.75 | 73,602 |
| 04/09/2024 | DDS | 556 | Direct | COM | $33.16 | $18,434.18 | 74,444 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research